Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501) is a research paper published in Annals of Surgical Oncology (2024). On theSindex it has a DataRank of 0.381. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0889
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
National Cancer Institute of the National Institutes of Health
Grant: U10CA180821
National Cancer Institute of the National Institutes of Health
Grant: U10CA180882
National Cancer Institute of the National Institutes of Health
Grant: UG1CA189850
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233290
National Cancer Institute of the National Institutes of Health
Grant: UG1CA233329
National Cancer Institute of the National Institutes of Health
Grant: U10CA180820
National Cancer Institute of the National Institutes of Health
Grant: U10CA180868
National Cancer Institute of the National Institutes of Health
Grant: U10CA180888
National Institutes of Health
Grant: 3U10CA180821-02S2
Alliance for Clinical Trials in Oncology Operations Center
National Institutes of Health
Grant: 5UG1CA233329-06
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
National Institutes of Health
Grant: 3UG1CA233290-06S1
Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
National Institutes of Health
Grant: 3UG1CA189850-11S1
Northwell Health NCORP
National Institutes of Health
Grant: 5U10CA180882-02
Statistics and Data Center for the Alliance for Clinical Trials in Oncology
National Institutes of Health
Grant: 5U10CA180868-09
NRG Oncology Network Group Operations Center
National Institutes of Health
Grant: 3U10CA180820-02S3
ECOG-ACRIN Operations Center
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: UG1 CA189823
FWCI
1.21
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals